2.2.1: Case Study- The $2 Million Gamble

Agile Project Management · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    2.2.1: Case Study- The $2 Million Gamble

    MediConnect Health

    MediConnect Health entered its Series A funding round with an ambitious promise. The startup planned to build an advanced patient portal that would connect directly with wearable devices and give patients access to health analytics, personalized recommendations, and an interactive dashboard. Investors responded enthusiastically, and the board approved a 12-month product roadmap. Engineering teams began producing detailed architecture diagrams, while the marketing group started developing launch campaigns built around the idea of a highly connected digital health experience. Within the company, the product was increasingly described as the platform that would distinguish MediConnect from a growing field of healthcare technology competitors.

    Six months into the planning effort, Chief Financial Officer Elena Park presented an updated financial forecast to the executive team. At the company's current spending rate, MediConnect had approximately nine months of funding remaining. The numbers created an immediate problem. The development organization now estimated that the planned product, including wearable integration, advanced analytics, personalized recommendations, and the patient dashboard, would require at least 15 months before it could be considered market-ready. Even the original 12-month target was beginning to look difficult. Elena summarized the issue simply: "Our roadmap extends beyond our runway."

    The leadership team struggled with what to do next. Vice President of Product Marcus Chen argued that reducing the scope could weaken MediConnect's position before it had even entered the market. Several competitors were already announcing partnerships with wearable-device companies. "Wearable integration is what makes us different," Marcus told the team. "If we launch without it, what exactly are we asking investors and customers to believe in?" Engineering leader Priya Raman viewed the situation differently. Her team had already spent months designing the infrastructure needed to support the broader platform, but she questioned whether continuing to build every planned capability was the best use of the company's remaining resources. "We know what we want to build," she said. "I'm less certain we know what patients will actually use."

    The disagreement became more difficult because both sides had legitimate concerns. Investors had funded MediConnect based partly on its broader technology vision, and changing direction could raise questions about the founding team's strategy. At the same time, continuing toward the complete platform could consume most of the company's remaining capital before patients had an opportunity to use any part of the product. Marketing worried that a limited first release might attract little attention. Engineering worried that waiting another year could leave the company with sophisticated technology but no established customer base. As meetings continued, the original roadmap began to feel less like a plan and more like a commitment that nobody wanted to be the first to challenge.

    Chief Executive Officer Sofia Bennett eventually proposed an alternative that surprised the leadership team. She wanted MediConnect to release a production-ready product in six weeks. It would not include wearable tracking, health analytics, personalized recommendations, or the advanced dashboard featured in the company's investor presentations. Instead, the initial portal would perform one function: appointment scheduling. Patients would be able to find available times and book appointments online rather than calling a clinic and waiting for staff assistance. Marcus looked at the proposed release and responded, "That's not the platform we raised money to build. That's one feature." Sofia replied, "Then we need to find out whether that one feature matters."

    The six-week release required the organization to change priorities quickly. Engineers focused on reliability, security, and integration with clinic scheduling systems rather than the larger wearable architecture. Marketing reduced its launch plans and positioned the portal around convenience instead of advanced health technology. When the scheduling service became available, patients began using it almost immediately. Within three months, approximately 40 percent of appointments at participating clinics were being booked through the portal. A process that had sometimes taken two or three days through phone calls could now be completed in roughly five minutes, and patient satisfaction scores increased during the same period.

    Those results created new questions rather than settling the earlier debate. The product team began contacting patients about future capabilities, including the wearable integration that had been central to MediConnect's original strategy. The response was far less enthusiastic than executives had expected. Some patients questioned why a relatively new company needed continuous access to their health information. Others raised concerns about privacy, data security, and how information collected from wearable devices might be stored or shared. Even some patients whom the product team had expected to be enthusiastic about connected health technology expressed hesitation. "I'll use the portal to book my doctor," one participant told a researcher. "I'm not ready to give it everything my watch knows about me."

    By the next leadership meeting, MediConnect faced a different decision from the one it had confronted six months earlier. Appointment scheduling was gaining adoption, and patients were also asking about practical services such as appointment reminders, prescription refills, and direct communication with clinicians. At the same time, the company had already invested substantial effort in the technical designs needed for wearable integration, and investors still expected MediConnect to build a differentiated health technology platform. Continuing with the original roadmap could preserve the company's initial vision. Redirecting resources toward the services patients were already requesting could produce faster adoption but would move MediConnect further from the product it had originally promised. With limited capital remaining and competing signals from investors, patients, and internal teams, Sofia asked the executives to decide what MediConnect should build next.

    Reflections and Pulse-Check \(\PageIndex{1}\)

    This section is designed for you to pause and consider how these leadership concepts land in your own professional world. There are no right or wrong answers here. Instead, these questions are meant to help you audit your current approach and identify where you might want to pivot.

    1. What factors should MediConnect's leadership consider when deciding whether to continue investing in wearable integration or redirect resources toward the services patients are currently requesting?
    2.  How should the leadership team balance its commitments to investors and its original product vision with the evidence emerging from actual patient behavior and feedback?
    3. If you were part of MediConnect's leadership team at the final meeting, what additional information would you want before deciding how to revise the product roadmap?

    This page titled 2.2.1: Case Study- The $2 Million Gamble was last modified on Sun, 30 Aug 2026 16:14:23 GMT and is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by Guharaman Janakiraman.